We observed significant acceleration of skin tumors and progression to invasive carcinomas, demonstrating the successful cooperation between the Kras and Arf pathways, but again, these mice failed to demonstrate a significant B-cell phenotype. The gene discussed is CDKN2A; the disease is skin neoplasm.